Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Revenue (Tables)

v3.22.1
Revenue (Tables)
 12 Months Ended
Dec. 31, 2021
Revenue from contracts with customers [Abstract]  
Disclosure of disaggregation of revenue from contracts with customers
For the Year Ended December 31,
2021 2020 2019
$’000 $’000 $’000
Value-based care
 220,852  26,038  — 
Software licensing
 60,052  24,603  2,002 
Clinical services
 42,017  28,631  14,032 
322,921  79,272  16,034 
Disclosure of receivables, contract assets, and contract liabilities The following table provides information about receivables, contract assets and contract liabilities from contracts with customers.
As of December 31,
2021 2020
$’000 $’000
Trade receivables (Note 20)
 8,278  4,674 
Contract assets (Note 20)
 4,484  2,378 
Contract liabilities (Note 8 iii)
 94,182  76,018 
Disclosure of performance obligations
The following table includes revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the reporting date:
2022 2023 2024 2025
2026
and
beyond
Total
$’000 $’000 $’000 $’000 $’000 $’000
As of December 31, 2021
 23,786  18,918  19,349  17,852  14,277  94,182 
Disclosure of contract liabilities
The table below shows significant changes in contract liabilities:
2021 2020
$’000 $’000
Balance on January 1
 76,018  81,584 
Amounts billed but not recognized
 61,176  18,080 
Revenue recognized
 (43,012) (23,646)
Balance on December 31
 94,182  76,018